EUVIMEDEUVIMED entdecken
Crossref

L26/P-800 A comparison between intrauterine insemination and in-vitro fertilization as a first treatment for women aged ≥39 using donor sperm

Y. Vardimon, E. Altman, A. Stein, O. Sapir, M. Sharon Weiner, A. Hochberg, Y. Shufaro, A. Ben-Haroush, A. Wertheimer

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y. Vardimon und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does initial in-vitro fertilization shorten time or reduce treatment cycles to pregnancy and live birth compared with intrauterine-insemination in women aged ≥39 using donor sperm? Summary answer Initiating treatment with in-vitro fertilization did not shorten the time to live birth or reduce the number of treatment cycles compared with initiating intrauterine insemination. What is known already Advanced maternal age is associated with declining fertility and lower pregnancy rates, even when donor sperm is used. In many fertility centers, intrauterine-insemination (IUI) is traditionally offered as first-line treatment, with progression to in-vitro fertilization (IVF) if unsuccessful. However, due to the narrowing fertility window at older ages, IVF is often considered earlier, and in Israel women aged 39-45 years are eligible for IVF as first-line treatment within the national health basket. While IVF offers higher per-cycle pregnancy rates, evidence regarding its advantage as an initial strategy in cumulative live birth outcomes remains limited, particularly in women using donor sperm. Study design, size, duration A retrospective cohort study was conducted at a tertiary fertility centre between 2009 and 2023. The study included 393 women aged ≥39 years without known infertility seeking donor sperm (DS). Participants were categorized by their initial treatment strategy: 206 initiated IUI and 187 initiated IVF. Participants/materials, setting, methods Women aged ≥39 years without known infertility factors, treated with DS at a tertiary fertility center, were included. Participants were grouped by initial treatment strategy: IUI or IVF. Baseline characteristics, treatment parameters, and clinical outcomes were collected. Outcomes included pregnancy rates, live birth rates, time to pregnancy and live birth, number of treatment cycles, and outcomes of the first IVF cycle. Survival analyses and propensity score adjustment were applied to control for potential confounders. Main results and the role of chance Live birth rates did not differ significantly between women who initiated treatment with IUI and those who initiated treatment with IVF, both after the initial treatment (6.8% vs. 9.1%, p = 0.46) and also when cumulative live birth rates were assessed (47.1% vs. 37.4%, p = 0.06). Among women starting with IUI, the pregnancy rate achieved by IUI was 26.2%, while 49.6% achieved pregnancy by IVF after transitioning from IUI. The median number of IUI cycles prior to transition to IVF was 2, and the median time to transition was 4.3 months. No significant differences were observed between the groups in time to pregnancy or time to live birth, nor in the number of treatment cycles required to achieve these outcomes. The likelihood of achieving live birth following the first IVF cycle was independent of the initial treatment strategy. After adjustment for age, baseline FSH, and parity, initiation with IUI was not associated with a longer overall treatment duration. Limitations, reasons for caution The retrospective design and non-randomised treatment assignment introduce potential selection bias. Despite propensity score matching, unmeasured confounders or differences in patient preferences may exist. Additionally, some patients were lost to follow-up after transferring to other centres, potentially affecting the completeness of cumulative outcome data. Wider implications of the findings In women aged ≥39 years using DS, initiation of treatment with IUI does not compromise live-birth outcomes compared with IVF. When baseline patient characteristics are considered, starting with IUI is not associated with longer treatment duration or increased treatment cycles, supporting individualized counselling and shared decision-making when selecting first-line treatment. Trial registration number No

Zitieren

APA

Vardimon, Y., Altman, E., Stein, A., Sapir, O., Weiner, M. S., Hochberg, A., Shufaro, Y., Ben-Haroush, A., & Wertheimer, A. (2026). L26/P-800 A comparison between intrauterine insemination and in-vitro fertilization as a first treatment for women aged ≥39 using donor sperm. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1127

Vancouver

Vardimon Y, Altman E, Stein A, Sapir O, Weiner MS, Hochberg A, et al. L26/P-800 A comparison between intrauterine insemination and in-vitro fertilization as a first treatment for women aged ≥39 using donor sperm. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1127

BibTeX
@article{Vardimon2026,
  author = {Vardimon, Y. and Altman, E. and Stein, A. and Sapir, O. and Weiner, M. Sharon and Hochberg, A. and Shufaro, Y. and Ben-Haroush, A. and Wertheimer, A.},
  title = {L26/P-800 A comparison between intrauterine insemination and in-vitro fertilization as a first treatment for women aged ≥39 using donor sperm},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1127}
}
Kostenlos starten →